Ameritas Advisory Services LLC raised its stake in The Allstate Corporation (NYSE:ALL - Free Report) by 108.3% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,197 shares of the insurance provider's stock after buying an additional 5,301 shares during the quarter. Ameritas Advisory Services LLC's holdings in Allstate were worth $2,084,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. Vantage Point Financial LLC raised its stake in Allstate by 3.6% during the first quarter. Vantage Point Financial LLC now owns 1,495 shares of the insurance provider's stock worth $310,000 after purchasing an additional 52 shares during the period. Confluence Wealth Services Inc. raised its position in shares of Allstate by 0.7% during the 1st quarter. Confluence Wealth Services Inc. now owns 8,000 shares of the insurance provider's stock valued at $1,558,000 after buying an additional 54 shares during the period. Achmea Investment Management B.V. lifted its holdings in Allstate by 0.3% in the first quarter. Achmea Investment Management B.V. now owns 20,586 shares of the insurance provider's stock valued at $4,262,000 after acquiring an additional 57 shares during the last quarter. Avidian Wealth Enterprises LLC grew its position in Allstate by 1.7% in the first quarter. Avidian Wealth Enterprises LLC now owns 3,552 shares of the insurance provider's stock worth $735,000 after acquiring an additional 59 shares during the period. Finally, Intrust Bank NA increased its stake in Allstate by 0.5% during the fourth quarter. Intrust Bank NA now owns 12,135 shares of the insurance provider's stock worth $2,340,000 after acquiring an additional 61 shares during the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.
Allstate Stock Down 2.7%
Allstate stock traded down $5.50 during trading on Wednesday, reaching $194.64. The stock had a trading volume of 1,516,099 shares, compared to its average volume of 1,632,636. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.40. The Allstate Corporation has a 52-week low of $157.50 and a 52-week high of $213.18. The stock has a market cap of $51.54 billion, a PE ratio of 13.30, a P/E/G ratio of 1.04 and a beta of 0.33. The business has a 50 day moving average price of $201.27 and a 200 day moving average price of $196.58.
Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.98 by ($0.45). The firm had revenue of $14.30 billion for the quarter, compared to analysts' expectations of $16.41 billion. Allstate had a return on equity of 24.62% and a net margin of 6.19%. During the same period last year, the firm posted $5.13 earnings per share. Allstate's revenue for the quarter was up 7.8% on a year-over-year basis. On average, analysts predict that The Allstate Corporation will post 18.74 EPS for the current year.
Allstate Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, July 1st. Stockholders of record on Monday, June 9th were issued a $1.00 dividend. The ex-dividend date of this dividend was Monday, June 9th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.06%. Allstate's payout ratio is currently 27.32%.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on ALL shares. Keefe, Bruyette & Woods increased their price target on Allstate from $228.00 to $235.00 and gave the stock an "outperform" rating in a report on Wednesday, May 7th. BMO Capital Markets reiterated an "outperform" rating on shares of Allstate in a research report on Friday, May 16th. Wells Fargo & Company decreased their price objective on shares of Allstate from $200.00 to $197.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Wall Street Zen upgraded shares of Allstate from a "hold" rating to a "buy" rating in a report on Thursday, May 1st. Finally, Evercore ISI boosted their target price on Allstate from $227.00 to $230.00 and gave the company an "outperform" rating in a research report on Thursday, May 1st. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, Allstate currently has an average rating of "Moderate Buy" and a consensus price target of $225.20.
Get Our Latest Stock Report on Allstate
Allstate Company Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading

Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.